{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:39:29Z","timestamp":1775295569006,"version":"3.50.1"},"reference-count":109,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bmc.2019.07.023","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T19:20:27Z","timestamp":1562959227000},"page":"3760-3774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Natural product derived promising anti-MRSA drug leads: A review"],"prefix":"10.1016","volume":"27","author":[{"given":"Srikanth","family":"Gatadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitendra","family":"Gour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Nanduri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.07.023_h0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/520193","article-title":"Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2","volume":"29","author":"Fridkin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2019.07.023_h0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/hs.2014.0088","article-title":"Antimicrobial resistance is a global health emergency","volume":"13","author":"Toner","year":"2015","journal-title":"Health Secur"},{"key":"10.1016\/j.bmc.2019.07.023_h0015","doi-asserted-by":"crossref","first-page":"16187","DOI":"10.1038\/nmicrobiol.2016.187","article-title":"Combating antimicrobial resistance globally","volume":"1","author":"Sugden","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bmc.2019.07.023_b0010","doi-asserted-by":"crossref","first-page":"11993","DOI":"10.1021\/acs.est.5b02566","article-title":"Role of the environment in the transmission of antimicrobial resistance to humans: a review","volume":"49","author":"Huijbers","year":"2015","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.bmc.2019.07.023_b0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1021\/cen-09240-govpol1","article-title":"Battling drug-resistant bacteria","volume":"92","author":"Erickson","year":"2014","journal-title":"Chem Eng News"},{"key":"10.1016\/j.bmc.2019.07.023_b0020","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1021\/acsomega.7b01368","article-title":"Antibiotic resistance: current perspectives","volume":"92","author":"Petchiappan","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2019.07.023_b0025","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1021\/acs.jmedchem.7b00215","article-title":"Pharmaceutical approaches to target antibiotic resistance mechanisms","volume":"60","author":"Schillaci","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0030","doi-asserted-by":"crossref","first-page":"12415","DOI":"10.1021\/acs.chemrev.7b00283","article-title":"Natural products as platforms to overcome antibiotic resistance","volume":"117","author":"Rossiter","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2019.07.023_b0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/acsinfecdis.7b00258","article-title":"Developments in glycopeptide antibiotics","volume":"4","author":"Blaskovich","year":"2018","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2019.07.023_b0040","doi-asserted-by":"crossref","first-page":"9292","DOI":"10.1021\/jm500941m","article-title":"Natural products in medicine: transformational outcome of synthetic chemistry","volume":"57","author":"Szychowski","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.bmc.2019.07.023_b0050","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1021\/ja01175a065","article-title":"Chloramphenicol (Chloromycetin). IV.1aChemical Studies","volume":"71","author":"Rebstock","year":"1949","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2019.07.023_b0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ja.2012.59","article-title":"Antibacterial activity of amphiphilic tobramycin","volume":"65","author":"Kubeer","year":"2012","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmc.2019.07.023_b0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.39.3.577","article-title":"Erythromycin resistance by ribosome modification","volume":"39","author":"Weisblum","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.07.023_b0065","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of Vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmc.2019.07.023_b0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1574-6968.1992.tb05089.x","article-title":"Co-transfer of Vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus","volume":"93","author":"Noble","year":"1992","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.bmc.2019.07.023_b0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","article-title":"Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance","volume":"1","author":"Hiramatsu","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2019.07.023_b0080","first-page":"335","article-title":"Streptogramin Antibiotics: Mode of Action and Resistance","volume":"3","author":"Johnston","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.07.023_h0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijmm.2017.12.002","article-title":"Differential daptomycin resistance development in Staphyloccocus aureus strains with active and mutated gra regulatory systems","volume":"308","author":"M\u00fcller","year":"2017","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.bmc.2019.07.023_h0100","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","article-title":"Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Hayden","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bmc.2019.07.023_b0090","first-page":"789","article-title":"Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities","volume":"3","author":"Walsh","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.bmc.2019.07.023_b0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/09546630510011810","article-title":"Tigecycline: A review of a new glycylcycline antibiotic","volume":"16","author":"Scheinfeld","year":"2005","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.bmc.2019.07.023_b0100","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1128\/AAC.01432-05","article-title":"Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci","volume":"50","author":"Jones","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.07.023_b0105","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.49.3.1127-1134.2005","article-title":"Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus","volume":"49","author":"Higgins","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.07.023_b0110","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1086\/648438","article-title":"Telavancin: a novel lipoglycopeptide","volume":"49","author":"Saravolatz","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2019.07.023_b0115","first-page":"2","article-title":"Aztreonam: the first monobactam","volume":"78","author":"Syke","year":"1985","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bmc.2019.07.023_b0120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cbpa.2008.03.016","article-title":"The impact of natural products upon modern drug discovery","volume":"12","author":"Ganesan","year":"2008","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bmc.2019.07.023_b0125","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1002\/anie.200600350","article-title":"Antibacterial natural products in medicinal chemistry\u2014exodus or Revival?","volume":"45","author":"Nussbaum","year":"2006","journal-title":"Angew Chem Int"},{"key":"10.1016\/j.bmc.2019.07.023_b0130","first-page":"182","article-title":"The pleuromutilin antibiotics: a new class for human use","volume":"11","author":"Novak","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.bmc.2019.07.023_b0135","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1021\/jm500312x","article-title":"Design, synthesis, and structure\u2212activity relationship studies of novel thioether pleuromutilin derivatives as potent antibacterial agents","volume":"57","author":"Ling","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0140","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1021\/jm500374c","article-title":"Synthesis and biological activities of novel pleuromutilin derivatives with a substituted thiadiazole moiety as potent drug-resistant bacteria inhibitors","volume":"57","author":"Shang","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0145","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1021\/jm8000136","article-title":"Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens","volume":"51","author":"Hirokawa","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0150","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ejmech.2017.01.004","article-title":"Design, synthesis and antibacterial evaluation of novel pleuromutilin derivatives possessing piperazine linker","volume":"127","author":"Gao","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0155","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bmcl.2011.12.063","article-title":"Design, synthesis, and structure\u2013activity relationship studies of conformationally restricted mutilin 14-carbamates","volume":"22","author":"Fu","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2019.07.023_b0160","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejmech.2016.09.054","article-title":"Structure-activity relationships and optimization of acyclic acylphloroglucinol analogues as novel antimicrobial agents","volume":"125","author":"Tan","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0165","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1021\/acs.jnatprod.5b00858","article-title":"Antistaphylococcal prenylated acylphoroglucinol and Xanthones from Kielmeyera variabilis","volume":"79","author":"Coqueiro","year":"2016","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0170","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1021\/np2003319","article-title":"Antibacterial acylphloroglucinols from Hypericum olympicum","volume":"75","author":"Shiu","year":"2011","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejmech.2018.05.038","article-title":"Total synthesis of acylphloroglucinols and their antibacterial activities against clinical isolates of multi-drug resistant (MDR) and methicillin-resistant strains of Staphylococcus aureus","volume":"155","author":"Rahman","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0180","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1021\/acs.jnatprod.5b00721","article-title":"Antibacterial prenylated acylphloroglucinols from Psorothamnus fremontii","volume":"78","author":"Yu","year":"2015","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0185","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1021\/np1004483","article-title":"Norlignans, acylphloroglucinols, and a dimeric xanthone from Hypericum chinense","volume":"73","author":"Wang","year":"2010","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0190","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/acs.jnatprod.5b00968","article-title":"Nortriketones: antimicrobial Trimethylated Acylphloroglucinols from Ma\u0305 nuka (Leptospermum scoparium)","volume":"79","author":"Killeen","year":"2016","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.resmic.2014.03.002","article-title":"Aspidin BB, a phloroglucinol derivative, exerts its antibacterial activity against Staphylococcus aureus by inducing the generation of reactive oxygen species","volume":"165","author":"Li","year":"2014","journal-title":"Res Microbiol"},{"key":"10.1016\/j.bmc.2019.07.023_b0200","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1021\/np060348t","article-title":"Epidithiodioxopiperazines with Anti-MRSA Activity, from Bionectra byssicola F120","volume":"69","author":"Zheng","year":"2006","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/np500755v","article-title":"Synthetic analogues of the marine bisindole deoxytopsentin: potent selective inhibitors of MRSA pyruvate kinase","volume":"78","author":"Veale","year":"2014","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0210","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/acsmedchemlett.8b00161","article-title":"Meridianin D analogues display antibiofilm activity against MRSA and increase colistin efficacy in Gram-negative bacteria","volume":"9","author":"Huggins","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2019.07.023_b0215","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/np1001225","article-title":"Antibiotic Indole Sesquiterpene Alkaloid from Greenwayodendron suaWeolens with a New Natural Product Framework","volume":"73","author":"Williams","year":"2010","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0220","doi-asserted-by":"crossref","first-page":"44716","DOI":"10.1074\/jbc.M111.289033","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA) Pyruvate Kinase as a Target for Bis-indole Alkaloids with Antibacterial Activities","volume":"286","author":"Zoraghi","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0225","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.1021\/jf901716j","article-title":"Identification and Bioactivities of Resveratrol Oligomers and Flavonoids from Carex folliculata Seeds","volume":"57","author":"Li","year":"2009","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0230","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1021\/acs.jmedchem.7b00380","article-title":"Semisynthetic flavone-derived antimicrobials with therapeutic potential against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"60","author":"Lin","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0235","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/jtbi.2000.2062","article-title":"Antibacterial activity of flavonoids against methicillin-resistant Staphylococcus aureus strains, as well as olympicin A and derivatives","volume":"205","author":"Alcaradz","year":"2000","journal-title":"J Theor Biol"},{"key":"10.1016\/j.bmc.2019.07.023_b0240","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1021\/np900499q","article-title":"Methicillin-Resistant Staphylococcus aureus (MRSA)-Active Metabolites from Platanus occidentalis (American Sycamore)","volume":"72","author":"Ibrahim","year":"2009","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0245","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1021\/jm200010x","article-title":"Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents","volume":"54","author":"Hossion","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0250","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1021\/np100668s","article-title":"Phytochemical studies on Stemona aphylla: Isolation of a new stemofoline alkaloid and six new stemofurans","volume":"74","author":"Sastraruji","year":"2011","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0255","doi-asserted-by":"crossref","first-page":"9819","DOI":"10.3390\/molecules16129819","article-title":"Synergistic antibacterial and antibiotic effects of Bisbenzylisoquinoline alkaloids on clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"16","author":"Zuo","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2019.07.023_b0260","first-page":"90","article-title":"Antibacterial alkaloids from Chelidonium majus Linn (Papaveraceae) against clinical isolates of methicillin-resistant Staphylococcus aureus","volume":"11","author":"Zuo","year":"2008","journal-title":"J Pharm Pharmaceut Sci"},{"key":"10.1016\/j.bmc.2019.07.023_b0265","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/np500281c","article-title":"In Vitro antibacterial activity of prenylated guanidine alkaloids from Pterogyne nitens and synthetic analogues","volume":"77","author":"Coqueiro","year":"2014","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0270","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/np3000365","article-title":"Bioactive carbazole alkaloids from Clausena wallichii roots","volume":"75","author":"Maneerat","year":"2012","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0275","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.fitote.2012.04.026","article-title":"Antibacterial carbazole alkaloids from Clausena harmandiana twigs","volume":"83","author":"Maneerat","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bmc.2019.07.023_b0280","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/acsmedchemlett.8b00094","article-title":"Discovery and development of 8-substituted cycloberberine derivatives as novel antibacterial agents against MRSA","volume":"9","author":"Fan","year":"2018","journal-title":"Med Chem Lett"},{"key":"10.1016\/j.bmc.2019.07.023_b0285","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ejmech.2018.08.050","article-title":"Synthesis and antibacterial evaluation of 13-substituted cycloberberine derivatives as a novel class of anti-MRSA agents","volume":"157","author":"Fan","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0290","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1039\/C8QO01180J","article-title":"Novel potential artificial MRSA DNA intercalators: synthesis and biological evaluation of berberine-derived thiazolidinediones","volume":"6","author":"Sun","year":"2019","journal-title":"Org Chem Front"},{"key":"10.1016\/j.bmc.2019.07.023_b0295","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1039\/C6MD00688D","article-title":"Design, synthesis and biological evaluation of novel Schiff base-bridged tetrahydroprotoberberine triazoles as a new type of potential antimicrobial agents","volume":"8","author":"Duan","year":"2017","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.bmc.2019.07.023_b0300","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.bmcl.2017.02.071","article-title":"Novel benzimidazolyl tetrahydroprotoberberines: Design, synthesis, antimicrobial evaluation and multi-targeting exploration","volume":"27","author":"Kumar","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2019.07.023_b0305","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1021\/acs.jmedchem.6b01403","article-title":"Symmetrically substituted xanthone amphiphiles combat grampositive bacterial resistance with enhanced membrane selectivity","volume":"60","author":"Lin","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0310","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejmech.2016.03.058","article-title":"Recent insight into the biological activities of synthetic xanthone derivatives","volume":"116","author":"Shagufta","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0315","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1080\/14786419.2017.1402315","article-title":"A novel xanthone dimer derivative with antibacterial activity isolated from the bark of Garcinia mangostana","volume":"32","author":"Wang","year":"2017","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmc.2019.07.023_b0320","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/acs.jmedchem.5b01500","article-title":"Non-peptidic amphiphilic xanthone derivatives: structure activity relationship and membrane-targeting properties","volume":"59","author":"Koh","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0325","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1021\/bi00010a034","article-title":"Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2","volume":"34","author":"Matsuzaki","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2019.07.023_b0330","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/jm501285x","article-title":"Amino acid modified xanthone derivatives: novel, highly promising membrane-active antimicrobials for multidrug-resistant gram positive bacterial infections","volume":"58","author":"Koh","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0335","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1021\/acs.jmedchem.6b01403","article-title":"Symmetrically substituted xanthone amphiphiles combat gram-positive bacterial resistance with enhanced membrane selectivity","volume":"60","author":"Lin","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0340","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1021\/jm301683j","article-title":"Design and synthesis of amphiphilic xanthone-based, membranetargeting antimicrobials with improved membrane selectivity","volume":"56","author":"Zou","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0345","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.bmcl.2016.05.030","article-title":"Caged xanthones: potent inhibitors of global predominant MRSA USA300","volume":"26","author":"Chaiyakunvat","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2019.07.023_b0350","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/np100422z","article-title":"Absolute configuration of (\u2212)-gambogic acid, an antitumor agent","volume":"26","author":"Ren","year":"2011","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0355","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1021\/acs.jnatprod.5b00410","article-title":"Flemingin-type prenylated chalcones from the sarawak rainforest plant Desmodium congestum","volume":"78","author":"Rees","year":"2015","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0360","doi-asserted-by":"crossref","first-page":"8398","DOI":"10.1021\/jm500853v","article-title":"Synthesis, structure\u2212activity relationship studies, and antibacterial evaluation of 4\u2013chromanones and chalcones, as well as olympicin A and derivatives","volume":"57","author":"Feng","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1453173","article-title":"Antibacterial activity of chalcone and dihydrochalcone compounds from Uvaria chamae roots against multidrug-resistant bacteria","author":"Koudokpon","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bmc.2019.07.023_b0370","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1039\/C5MD00527B","article-title":"Glabridin-chalcone hybrid molecules: drug resistance reversal agent against clinical isolates of Methicillin-Resistant Staphylococcus aureus","volume":"7","author":"Kapkoti","year":"2016","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.bmc.2019.07.023_b0375","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jep.2007.11.037","article-title":"Antimicrobial potential of Glycyrrhiza glabra roots","volume":"116","author":"Gupta","year":"2008","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bmc.2019.07.023_b0380","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1021\/acs.jmedchem.7b01634","article-title":"Design and syntheses of highly potent teixobactin analogues against Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin-resistant enterococci (VRE) in Vitro and in Vivo","volume":"61","author":"Parmar","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0385","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/jac\/dkv175","article-title":"Teixobactin, the first of a new class of antibiotics discovered by iChip technology?","volume":"70","author":"Piddock","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2019.07.023_b0390","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1021\/acschembio.6b00295","article-title":"Elucidation of the teixobactin pharmacophore","volume":"11","author":"Yang","year":"2016","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2019.07.023_b0395","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/acs.jnatprod.6b01179","article-title":"Penicilones A\u2212D, anti-MRSA azaphilones from the marine-derived fungus Penicillium janthinellum HK1\u20136","volume":"80","author":"Chen","year":"2017","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0400","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1021\/cr300402y","article-title":"Azaphilones: chemistry and biology","volume":"113","author":"Gao","year":"2013","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2019.07.023_b0405","first-page":"329","article-title":"Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo activity against MRSA that inhibits MenB in the bacterial menaquinone biosynthesis pathway","volume":"2","author":"Matarlo","year":"2016","journal-title":"Infect Dis"},{"key":"10.1016\/j.bmc.2019.07.023_b0410","first-page":"241","article-title":"Biosynthesis of vitamin K (menaquinone) in bacteria","volume":"46","author":"Bentley","year":"1982","journal-title":"Infect Dis"},{"key":"10.1016\/j.bmc.2019.07.023_b0415","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1021\/jm070638m","article-title":"Discovery of 1,4-didydroxy-2-naphthoate prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens","volume":"50","author":"Kurosu","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0420","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5582\/ddt.2016.01041","article-title":"Menaquinone as a potential target of antibacterial agents","volume":"10","author":"Paudel","year":"2016","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.bmc.2019.07.023_b0425","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1021\/jm201467r","article-title":"Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy","volume":"55","author":"Clark","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0430","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","article-title":"Review of eravacycline, a novel fluorocycline antibacterial agent","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2019.07.023_b0435","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1128\/AAC.06187-11","article-title":"Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic","volume":"56","author":"Grossman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.07.023_b0440","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1021\/jm070831g","article-title":"Antimicrobial lexitropsins containing amide, amidine, and alkene linking groups","volume":"50","author":"Anthony","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0445","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0022-2836(71)90250-6","article-title":"Interaction of the oligopeptide antibiotics netropsin and distamycin a with nucleic acids","volume":"58","author":"Zimmer","year":"1971","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2019.07.023_b0450","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejmech.2018.11.022","article-title":"Synthesis, Antimicrobial activity, attenuation of aminoglycoside resistance in MRSA, and ribosomal A-site binding of pyrene-neomycin conjugates","volume":"163","author":"Story","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0455","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0195-6701(81)90003-7","article-title":"Antibiotic-resistant Staphylococcus aureus","volume":"2","author":"Shanson","year":"1981","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.bmc.2019.07.023_b0460","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejmech.2017.06.065","article-title":"Antibiofilm potential of 16-oxo-cleroda-3, 13(14) E-diene-15 oic acid and its five new g-amino g-lactone derivatives against methicillin resistant Staphylococcus aureus and Streptococcus mutans","volume":"138","author":"Khan","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0465","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1286-4579(99)80003-3","article-title":"Antimicrobial properties of allicin from garlic","volume":"1","author":"Ankri","year":"1999","journal-title":"Microbes Infect"},{"key":"10.1016\/j.bmc.2019.07.023_b0470","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ejmech.2017.10.018","article-title":"Allicin-inspired pyridyl disulfides as antimicrobial agents for multidrug-resistant Staphylococcus aureus","volume":"143","author":"Sheppard","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0475","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1039\/C8MD00257F","article-title":"Structural optimization and antibacterial evaluation of rhodomyrtosone B analogues against MRSA strains","volume":"9","author":"Zhao","year":"2018","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.bmc.2019.07.023_b0480","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1021\/np500187c","article-title":"Antimicrobial constituents of the mature carpels of Manglietiastrum sinicum","volume":"77","author":"Ding","year":"2014","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0485","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1021\/np200720v","article-title":"Flavimycins A and B, dimeric 1,3-dihydroisobenzofurans with peptide deformylase inhibitory activity from Aspergillus flavipes","volume":"75","author":"Kwon","year":"2012","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0490","first-page":"14","article-title":"Antibacterial activity and action mechanism of questin from marine Aspergillus flavipes HN4-13 against aquatic pathogen Vibrio harveyi. 3","volume":"9","author":"Guo","year":"2019","journal-title":"Biotech"},{"key":"10.1016\/j.bmc.2019.07.023_b0495","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1021\/np3001128","article-title":"Trigoflavidols A\u2212C, degraded diterpenoids with antimicrobial activity, from Trigonostemon flavidus","volume":"75","author":"Tang","year":"2012","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0500","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1021\/np3006919","article-title":"Khayseneganins A\u2212H, limonoids from Khaya senegalensis","volume":"76","author":"Yuan","year":"2012","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0505","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/np400301d","article-title":"On the Antibiotic and antifungal activity of pestalone, pestalachloride A and structurally related compounds","volume":"76","author":"Augner","year":"2013","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.07.023_b0510","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1021\/jm501872s","article-title":"Structure diversification of Vancomycin through peptide-catalyzed, site-selective lipidation: a catalysis-based approach to combat glycopeptide-resistant pathogens","volume":"58","author":"Yoganathana","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.07.023_b0515","first-page":"166","article-title":"Vancomycin treatment failure in a vancomycin susceptible methicillin-resistant Staphylococcus aureus (MRSA) infected patient","volume":"64","author":"Norazah","year":"2009","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.bmc.2019.07.023_b0520","doi-asserted-by":"crossref","DOI":"10.1086\/425129","article-title":"Failure of vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections","volume":"39","author":"Howden","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2019.07.023_b0525","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ijantimicag.2015.05.014","article-title":"In vivo efficacy and pharmacological properties of a novel glycopeptide (YV4465) against vancomycin-intermediate Staphylococcus aureus","volume":"46","author":"Yarlagadda","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2019.07.023_b0530","first-page":"143","article-title":"Delivery of Novel Vancomycin Nanoplexes for Combating Methicillin Resistant staphylococcus aureus (MRSA) Infections","volume":"558","author":"Hassan","year":"2019","journal-title":"Int J Antimicrob Agents"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619309526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619309526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:04:59Z","timestamp":1760835899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619309526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":109,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0968089619309526"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.07.023","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural product derived promising anti-MRSA drug leads: A review","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}